Acquired Bleeding Disorder Completed Phase 2 Trials for Catridecacog (DB09310)

IndicationStatusPhase
DBCOND0030736 (Acquired Bleeding Disorder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00914589Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart SurgeryPrevention